• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

PE Firm Exploring Sale of HealthChannels’ Portfolio of 4 RCM Companies

by Fred Pennic 06/11/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

PE Firm Exploring Sale of HealthChannels’ Portfolio of 4 RCM Companies

Vesey Street Capital Partners (VSP), a strategic private equity firm with substantial and differentiated Healthcare Services sector and sourcing expertise is exploring the sale of its portfolio company HealthChannels. With 13,000 employees across 50 states and three countries, HealthChannels is comprised of four highly specialized revenue cycle management companies:

– ScribeAmerica, the nation’s most frequently used medical scribe company, with a reach of over 30 million patients through more than 1,700 hospital partners.

– QueueLogix, a software and service organization that closes the gap between medical back-office activities and frontline patient encounters through its proprietary SaaS platform and coding and clinical experts.

– CareThrough, a 360-degree care management solution that improves quality of care, patient engagement, and financial outcomes through its highly skilled care navigation coordinators.

– Soundlines, an intuitive, AI platform that aggregates clinical data from across the care continuum to streamline documentation, improve overall revenue cycle operations, and empower care team management.

In October 2017, VSCP led the recapitalization of HealthChannels, a holding company with three distinct segments that collectively meet the full range of providers’ increasingly complex healthcare data and documentation needs. Jefferies and Centerview Partners have been hired by VSP to advise them on the potential sale.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: AI, care management, Healthcare Data, Healthcare Mergers & Acquisitions, medical back-office, Partners, patient engagement, Private Equity, rcm, revenue cycle, Revenue Cycle Management, revenue cycle operations

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |